Identification and Validation of a Novel Antibacterial Compound MZ-01 against Methicillin-Resistant Staphylococcus aureus

The discovery of new classes of antibiotics is slow, and it is being greatly outpaced by the development of bacterial resistance. This disparity places us in an increasingly vulnerable position because we are running out of safe and effective therapeutic options to treat antibiotic-resistant infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Junshu, Brown, Christopher, Noland, Wayland, Johnson, Timothy J., Ji, Yinduo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686779/
https://www.ncbi.nlm.nih.gov/pubmed/36358205
http://dx.doi.org/10.3390/antibiotics11111550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686779/
https://www.ncbi.nlm.nih.gov/pubmed/36358205
http://dx.doi.org/10.3390/antibiotics11111550

Ejemplares similares